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Physical activity brings several beneficial effects on cardiovascular disease and in various 
metabolic disorders. The gallbladder is the dynamic reservoir of  concentrated bile containing 
cholesterol, bile acids, and phospholipids as micelles and vesicles. Such lipid carriers depend 
on hepatic synthesis and play a key role in digestion and absorption of  intestinal nutrients 
and cholesterol, in concert with intestinal motility. Bile acids also act as metabolically active 
hormones through interaction with small intestinal farnesoid-X receptor and GPBAR-1 
receptor across the enterohepatic circulation. The gallbladder, however, can become the “fellow 
traveller” with several metabolic disorders (obesity, diabetes, insulin resistance, dyslipidaemia, 
nonalcoholic liver steatosis) and metabolic syndrome. In this context, aggregation and growth 
of  excess biliary cholesterol into microcrystals and then macro-cholesterol gallstones may 
occur in the gallbladder. Notably, physical activity supports also benefits on the hepatobiliary 
tract, and via activation of  bile acids acting as signalling molecules. Researchers should know 
that initial training condition, volume, age, intensity, aerobic capacity, body weight, and 
percent of  body fat appear to interact with exercise-related health consequences. Thus, the 
overall beneficial effects of  physical activity extend beyond the cardiovascular health, and 
involve the hepatobiliary health.
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4. Introduction
Chronic diseases affect the vast majority of  the elderly 
populations, and sedentary life contributes to the raising trend of  
chronic disease epidemics. This detrimental effect starts already 
during childhood and adolescence. Sedentary lifestyle brings 
negative effects on the cardiovascular system and overall health 
[1]. Little to no physical activity contributes to the onset of  Type 
2 Diabetes (T2D), Cardiovascular Disease (CVD) and premature 
mortality in the long-term [2]. Regular physical activity, by 
contrast, has beneficial effects on several chronic diseases [2], 
the cardiovascular system, and decreases the risk of  CVD and 
mortality by all causes [3]. Obesity and hyperlipidaemia, as well 
as T2D, are components of  the metabolic syndrome, a complex 
aggregation of  conditions further complicated by cholesterol 
cholelithiasis [4, 6]. The effects of  physical activity, within the 
policy of  healthier lifestyles, might also extend beyond the simple 
benefits on CVD, involving the hepatobiliary tract (and vice-
versa). 
Here, we discuss the mechanisms relating physical activity to 
gallbladder disease and the hepatobiliary tract.  
5. General Aspects of  Exercise 
Evidences show that unfit individuals have increased risk to die 
(2-3 times more) at follow-up when compared with their more 
fit counterparts. This worrisome trend occurs regardless of  body 
habitus, or the presence of  CVD. At variance with the unmodifiable 
genetic, age and gender factors, physical inactivity is a modifiable 
risk factor. Clinicians can properly assess and prescribe -virtually to 
all subjects- physical activity within a structured lifestyle program. 
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Table 1 depicts the exact terminology and purpose of  different 
types of  exercise. Determination of  intensity of  exercise allows 
tailoring high-intensity or moderate-intensity activities. This step 
requires the calculation of  specific parameters. For example, 
Metabolic Equivalents (MET) compare the VO2 produced 
during a certain activity with resting VO2 (1 MET=3.5 mL per kg 
b.w./min) [7, 8]. In this context, the intensity of  aerobic activity 
is grouped into light (2-3 METs), moderate (4-6 METs), vigorous 
(8-12 METs), and near maximal (14-20 METs) [9]. Notably, even 
moderate-intensity exercise brings significant health benefits [8]. 
Current guidelines in the USA, Canada, Australia and Europe for 
adults recommend at least 150 min/week of  moderate-intensity 
exercise such as brisk walking) [10-14]. 
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6. Gallstone Disease 
Cholelithiasis (either asymptomatic or symptomatic with or 
without the gallbladder in situ after cholecystectomy, with or 
without complications) [15, 16]  is a highly prevalent condition, 
and one of  the most expensive digestive diseases worldwide. 
Almost 20 million Americans (10-15% of  adults in Europe 
and the USA) suffer from gallbladder disease [17, 18], and the 
raising incidence rate is 0.60-1.39% yearly [19]. The prevalence of  
gallstones is rising because of  the increasing obesity worldwide 
[20, 21], metabolic syndrome [6, 22, 23], T2D [24-27] and 
insulin resistance [27, 28]. Additional factors include reduced 
high density lipoproteins (HDL) and hypertriglyceridemia [29], 
sedentary lifestyles [30, 31], hormone replacement therapy 
[30] and fast food consumption [30]. The risk of  developing 
symptomatic gallstones prone to cholecystectomy also increases 
with obesity [32-38]. As the prevalence of  cholelithiasis increases 
worldwide (mainly because of  metabolic epidemics), the chance 
that biliary symptoms without or with complications will develop 
also increases (Table 2). 
In westernized countries, about 75% of  stones consist 
of  aggregated monohydrate cholesterol crystals, and the 
pathogenesis is closely related to metabolic abnormalities [17, 22].
Black pigment stones represent about 20%, and brown pigment 
stones only about 5% [39-42]. The most important pathogenic 
factors for cholesterol gallstones include (Figure 2):  
- Genetic factors which involve lithogenic (LITH) genes 
[43, 44] 
- Hepatic hypersecretion of  cholesterol leading to a 
sustained supersaturated gallbladder bile [45]
- Rapid phase transitions of  excess biliary cholesterol 
which results in precipitation and aggregation of  solid cholesterol 
crystals [46, 47] (Figure 3)
- Defective gallbladder motility (gallbladder stasis) [48-
53] with hypersecretion and luminal accumulation of  mucin gel 
secreted by the gallbladder epithelium which is exposed to an 
immune-mediated inflammation [54]
- Intestinal factors involving increased absorption of  
cholesterol in the small intestine, slow intestinal motility, and 
altered gut microbiota [15, 16, 55]. 









Biliary enteric fistula and gallstone ileus*
Choledocholithiasis
Cholestatic jaundice*
Cholesterolosis and gallbladder polyps
Chronic cholecystitis
Gallbladder carcinoma and porcelain gallbladder
Recurrent pyogenic cholangitis*
Table 2: Clinical manifestations of  gallstones
Type / Definition Examples / Purpose
Physical activity Jogging, walking, dancing, swimming 
gardening, heavy physical labor, car washing, 
etc.
Sustained body movement / Increased 
energy expenditure [8]
Exercise 
Planned, regularly repeated, intentional 
physical exercise
Maintains health and fitness [8, 114]
• Aerobic (endurance) exercises
Walking, running
Increased CV and respiratory fitness
• Strength (resistance) exercises Weight lifting or bodyweight resistance
Increased muscular strength
• Balance exercises
Tai chi, heel-toe walking Improved balance,
proprioception Prevention of falls
• Mobility (flexibility) exercises Yoga, stretching Maintenance or improved joint motions Muscle lengthening
Physical fittness - Heath-related (CV, muscular endurance, mobility, muscular strength, body composition)
- Regular activity allowing vigorous tasks 
without undue fatigue




Figure 1: The ternary equilibrium cholesterol-taurocholate-
phosphatidylcholine phase diagram as originally depicted by Wang et al. 
[47].  
Components appear as mole percent. The one-phase (φ) (micellar) zone is at the 
bottom, on the left is the two-phase zone (containing micelles and solid cholesterol 
crystals), then a central three-phase zone (containing micelles, liquid crystals and 
solid cholesterol crystals), and a right two-phase zone (containing micelles and 
liquid crystals). At the bottom, phospholipids (bile salts + phospholipids) molar 
ratios are also given, which is abbreviated as PL/(BS+PL). Interrupted lines 
indicate identical PL/(BS+PL) molar ratios, as in the case of  the 3 model bile 
systems plotting on the line (in this case ratio of  0.2). Adapted from Portincasa 
P, van Erpecum KJ, Di Ciaula A, Wang DQ. The physical presence of  gallstone 
modulates ex vivo cholesterol crystallization pathways of  human bile. Gastroenterol 
Rep (Oxf) 2019; 7: 32-41 [116].
Figure 2: Role of  physical activity appears together with lifestyle 
opportunities on pathogenic factors involved in the formation of  
cholesterol gallstones.  Therapeutic interventions include also general lifestyle 
recommendations, dietary changes, regular physical activity, and cure and 
prevention of  metabolic abnormalities. Excess cholesterol plays a key role at 
different places as solubilized molecule or solid (anhydrous, monohydrate) crystals 
or stones [15, 16, 45, 63, 115-117]. Adapted from: Di Ciaula A, Portincasa P. 





Figuereido et al., 
2017 [88] Clinical Study
Vigorous 
physical activity
Vigorous physical activity: inverse 
association with risk of  gallbladder 
disease
Li et al., 2017 [89] Clinical Study Aerobic capacity level
Progressively increasing aerobic 
capacity level: lower prevalence of  
gallbladder disease
Talseth et al., 
2016 [90] Clinical Study
Vigorous 
physical activity
Increasing the load of  physical activity: 
reduced risk for cholecystectomy
Henao-Moran et 
al., 2014 [91] Clinical Study
General 
physical activity
Increasing the load of  physical activity: 
protection against asymptomatic 
gallstones




Highest level of  physical activity: 






Higher aerobic capacity level and 





Sedentary physical activity associated 
with hospital admission for gallbladder 
disease




Higher levels of  physical activity 





Potential decrease of  gallstones and 
gallbladder cancer
Table 3: Benefits of  physical activity on gallbladder diseases
7. Physical Activity and Gallbladder Disease 
Physical activity affects gallbladder function, while decreasing 
the risk of  gallstone disease and gallbladder disease. Mechanisms 
involved, however, require further elucidations with respect to 
cholesterol absorption, synthesis and secretion, gallbladder and 
intestinal motility, and neuro-hormonal aspects [56]. American 
Indians have a high risk of  metabolic disorders and cholesterol 
gallstones. A previous ultrasonographic study found that physical 
activity related significantly and inversely to the development of  
gallbladder disease in a population at high risk for gallbladder 
disease (N=3143 subjects of  both sexes, from 13 American Indian 
communities examined at baseline in 1989-92 and at follow-up in 
1993-95). Results persisted irrespective of  potential confounders 
(body mass index), sex, and in individuals without diabetes (not 
in those with diabetes) [57]. We recently reviewed the topic of  
lifestyles in the guidelines by the European Association for the 
Study of  the Liver (EASL).  The protective effect of  physical 
activity on cholesterol gallstone formation is evident [20, 31, 58-
61]. About 20% of  gallstone patients (irrespective of  the type 
of  gallstones, i.e. cholesterol or pigment) will develop biliary 
symptoms, a condition which requires either medical attention or 
cholecystectomy [15-17, 62, 63]. In this context, questionnaire-
based surveys found that physical activity is able to decrease the 
risk of  symptomatic gallstones by one-third [31, 57, 58, 64, 65]. 
Two factors leading to CVD risk, such as physical inactivity and 
overnutrition, are precursors to increased body mass index and 
hepatic cholesterol synthesis rate [66]. Deposition of  metabolically 
active visceral fat, moreover, increases gastrointestinal morbidity 
and mortality (due to gallstone disease, tumors, and endoscopy 
complications) [67].  
The European Prospective Investigation into Cancer (EPIC-
Norfolk study) [68], using a validated questionnaire, investigated 
25,639 volunteers (aged 40–74 years) monitored for symptomatic 
gallstones. Four groups of  increasing physical activity were 
examined after 5 and 14 years. The highest level of  physical 
activity (equivalent to exercising for 1 h a day in a sedentary job, 
or 30 min a day in a standing job, or heavy manual job without any 
additional activity) was associated with a 70% decreased risk of  
symptomatic gallstones in both sexes. Physical exercise appears 
to influence key pathogenic mechanisms of  gallstone disease. 
Regular exercise decreases insulin levels [69] as well as insulin 
resistance [70]. By contrast, hyperinsulinemia promotes hepatic 
cholesterol uptake [71] and this situation, in turn, increases the 
secretion of  biliary cholesterol [72], while decreasing the secretion 
of  bile acids [73]. Notably, both conditions predispose to the 
accumulation of  cholesterol in bile, making the environment 
supersaturated with excess cholesterol [62, 63]. Physical exercise 
has also several effects on lipid metabolism: reduces serum 
cholesterol and triglycerides, as shown by a large meta-analysis 
[74], and increases serum HDL levels [75, 76]. This effect is 
important since serum HDL represents a marker of  reverse 
cholesterol transport to the liver [77], and is the precursor of  bile 
acid synthesis [78]. In turn, this HDL-mediated pathway would 
participate in mechanisms leading to decreased biliary cholesterol 
saturation [55]. In line with this possibility, studies found that 
serum HDL levels are inversely related to gallstone prevalence 
[79]. The beneficial effects of  physical exercise might also extend 
to the control of  the fatty acid-dependent hypersecretion of  
gallbladder mucin [80, 81], which is another event playing a role 
in the pathogenesis of  cholesterol cholelithiasis [17, 66, 82]. 
Physical activity has a prokinetic effect on the intestine [83] 
and appears to stimulate hormonal mechanisms, such as the 
cholecystokinin-dependent gallbladder contraction [84]. While 
keeping the ideal weight and losing excess weight is part of  healthy 
lifestyles to prevent gallstone disease and metabolic disorders [7, 
85, 86], rapid weight loss can lead to opposite effects. In fact, 
rapid mobilization of  body cholesterol and increased secretion 
in bile increase the risk of  gallstones formation in almost one 
third of  the subjects [66]. Thus, the degree of  obesity as well as 
rapidity of  weight loss are crucial in developing gallstones [87].  
A detailed list of  benefits of  physical activity performance on the 
gallbladder is depicted in Table 3. Vigorous physical activity was 
inversely associated with risk of  gallstone disease [88]. Aerobic 
capacity related to prevalence of  gallbladder disease; an increase 
in aerobic capacity by one metabolic equivalent task (MET) 
reduced the odd of  suffering from gallbladder disease by 8% and 
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13%, in men and women respectively [89]. Increasing the load 
of  vigorous physical activity was also associated with reduced 
risk for cholecystectomy [90], and in another study in adult 
women it protected against gallstones formation [91]. Similarly, 
higher levels of  physical activity might be associated with a 70% 
reduction of  risk for symptomatic gallstones, as reported in a 
five-year long study [68]. Vigorous aerobic exercise, as measured 
by aerobic capacity, was also inversely associated with gallbladder 
disease risk [92]. Hospital admission for gallbladder disease 
appears to be inversely associated to physical activity as well [93, 
94]. Further benefits are evident by increasing the intensity of  
physical activity in patients with gallbladder disease, as seen for 
vigorous vs. non-vigorous physical activity [95]. Notably, regular 
aerobic exercise may favorably influence the progression of  both 
gallstones formation and gallbladder cancer [96].  
One of  the main pro-kinetic effects of  physical activity affecting 
gastrointestinal function relies on the release of  cholecystokinin 
(CCK) [97, 98]. Not only gastrointestinal function, but also hunger 
has been influenced by this gastrointestinal hormone, as shown 
in a study involving acute exercise (from 30 to 120 min), which 
resulted in suppression of  hunger [99]. Improvement of  smooth 
muscle contractility by physical activity might also reinforce 
gallbladder emptying and refilling processes, two factors involved 
in the pathogenesis of  gallbladder disease [52, 100]. The exact 
confirmation of  the role of  any physical activity in gallbladder 
disease deserves further attention. To achieve this goal fully, 
measurements that are more objective would be required (such 
as accelerometers) [57].  
8. Bile Acid Metabolism and Physical Activity 
Bile acids (BAs) are soluble amphiphiles and constitute the main 
lipid component of  bile. BAs are synthetized from cholesterol 
and stored in the gallbladder particularly during fasting.  
The enterohepatic circulation of  BAs consists of  few steps [101-
103]: 
- Hepatic synthesis of  “primary” BAs (colic acid, CA; 
chenodeoxycholic acid, CDCA) from cholesterol. The essential 
enzymes are the rate-limiting microsomal enzyme cholesterol 
7-α-hydroxylase (CYP7A1), the sterol 12-α-hydroxylase (CYP8B1) 
at a later step (the “classical pathway”), the sterol 27-hydroxylase 
(CYP27A1) (the “alternative pathway”). The synthesized 
BAs, after conjugation with taurine or glycine to increase their 
solubility, are secreted into bile and enter the gallbladder. 
- With ingestion of  food, cholecystokinin (CCK) plasma 
levels increase, as the consequence of  fat-induced stimulation of  
upper enterocytes. CCK is a potent agonist of  CCK receptors 
(CCK-R) in the gallbladder smooth muscle and neurones. 
Activation of  CCK-R stimulates gallbladder contraction and flow 
of  bile and BAs into the duodenum (together with cholesterol and 
phospholipid, solubilized in 95% water as micelles and vesicles). 
These cholesterol carriers in bile help the intestinal digestion and 
absorption of  lipids and fat-soluble vitamins [55, 101, 104].
- Secreted BAs undergo effective active reabsorption 
(>95%) in the terminal ileum into the portal vein [101]. The 
remaining BAs which enter the colon are transformed by the 
resident gut microbiome into “secondary” BAs (deoxycholic 
acid, DCA and litocholic acid, LCA), and “tertiary” BAs 
(ursodeoxycholic acid, UDCA), which are then passively 
reabsorbed.  
- The continuous recirculation of  BAs to the liver across 
the portal vein is such that only 5% of  daily synthetized BAs 
are lost into feces, while 10-50% of  peripheral reabsorbed BAs 
undergo spillover into systemic circulation [101]. BAs act as 
special “hormones” because they display additional metabolic 
effects involving the liver, the intestine, and other tissues. BAs 
in the terminal ileum activate the orphan farnesoid X receptor 
(FXR). FXR, in turn, increases the transcription of  the enterokine 
fibroblast growth factor 19 (FGF19 in humans) [101], with 
gallbladder (relaxation, refilling with freshly synthetized hepatic 
bile) and liver effects involving BA synthesis. BAs also activate 
the ileal G protein-coupled receptor (GPBAR-1), and this step 
leads to the secretion of  peptide YY (PYY), glucagon-like 
peptide 1 (GLP-1) and glucagon-like peptide 2 (GLP-2). BAs help 
modulating the epithelial cell proliferation, gene expression, and 
energy, glucose, lipid and lipoprotein metabolism via activation 
of  intestinal foresaid X receptor (FXR) and G-protein-coupled 
bile acid receptor-1 (GPBAR-1), which are found in the intestine, 
brown adipose tissue and musculoskeletal muscle [6, 7, 101, 
103, 105]. BAs also have antimicrobial and anti-inflammatory 
functions [101].  
Physical activity could ameliorate BA metabolism by improving 
gastrointestinal motility (gallbladder, intestine). This aspect is still 
a matter of  debate [106]. Previous studies in animals showed 
that moderate physical activity increases BA excretion [107-
109]. As mentioned earlier, the recirculating FGF19 ultimately 
activates the hepatic FGF4 receptor/β-clotho and subsequent 
small heterodimer-mediated inhibition of  BA synthesis [101]. 
In principle, by increasing intestinal motility, BA flow as well as 
FXR expression would increase. A recent study in mice, however, 
demonstrated that physical activity stimulates BA secretion and 
fecal output. This mechanism probably involves increased reverse 
cholesterol transport and independent upregulation of  genes 
involved in BA synthesis, as well as FXR-FGF19 feedback [110]. 
Additional mechanisms include metabolic post-transcriptional 
pathways (increased fatty acid absorption). In the clinical setting, 
however, both fecal and serum BA concentrations decreased 
significantly in runners [111, 112], but the study did not investigate 
FXR function. It is still unknown whether physical activity might 
be able to produce additional BA/GPBAR-1-mediated mediated 
metabolic or anti-inflammatory effects, due to an apparent lack 
of  translational results from clinical to animal studies.  
9. Conclusion and Future Perspectives 
In general, physical activity is the only valid scientific therapeutic 
approach to counteract sedentary dysfunctions as well as the 
increasing trends of  several chronic diseases [2]. Physical activity 
should be an integral component of  healthy lifestyles aimed 
at maintaining the ideal weight, to achieve the ideal weight or 
– in subjects unable to attain and maintain substantial weight 
reduction – to plan a modest weight loss (≤10%) [113]. Beside 
the numerous beneficial metabolic and cardiovascular effects, 
physical activity targets also the biliary tract. This aspect 
raises the possibility that physical activity (many possibilities 
investigated so far) would play a role as therapeutic tool in 
primary (and secondary) prevention of  gallbladder disease 
(i.e. gallbladder hypomotility, gallstone disease, symptomatic 
gallstones and subsequent cholecystectomy). The benefits of  
physical activity might extend to the gastrointestinal function and 
the enterohepatic re-circulation of  bile acids acting as hormone-
like signaling agents and undergoing continuous enterohepatic 
recirculation. Further research should explore measurements that 
are more accurate, in order to dissect distinctive outcomes of  
each physical activity modality. Future studies should also explore 
the main beneficial and harmful effects of  physical activity in 
cohorts exposed to different nutrition intake, weight changes, or 
initial physical condition of  the individual.
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